Valeant Pharma

Visual Financials
Company Name: Valeant Pharmaceuticals International Inc
Ticker Symbol: VRX
CIK Number: 0000885590
WWW Address: http://www.valeant.com
CEO: Mr. Joseph C. Papa
No. of Employees: 800
Common Issue Type: CS
Business Description:Valeant Pharmaceuticals International Inc is a specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.

 
Industry Information: DRUGS - Drug Delivery [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 15.46 Up 0.02 - - 15.44 15.89 15.35 9223041
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 5,372.9 347.5 0.00 -0.85 0.00 0.0 0.0 119.87 - 13.77
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close15.47$
PE Ratio - LTM0.0
Market Capitalisation5,372.9mil
Latest Shares Outstanding347.5mil
Earnings pS (EPS)-0.85$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee474,841$
Effective Tax Rate0.0%
Float257.5mil
Float as % of Shares Outstanding0.8%
Foreign Sales10,113mil
Domestic Sales334mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin75.3%
EBITDA Margin38.6%
Pre-Tax Profit Margin-1.5%
Assets Turnover27.7%
Return on Assets (ROA)-0.8%
Return on Equity (ROE)-5.2%
Return on Capital Invested (ROCI)3.0%
Current Ratio1.0
Leverage Ratio (Assets/Equity)8.3
Interest Cover0.9
Total Debt/Equity (Gearing Ratio)5.26
LT Debt/Total Capital84.0%
Working Capital pS0.56$
Cash pS0.00$
Book-Value pS15.24$
Tangible Book-Value pS-102.79$
Cash Flow pS6.68$
Free Cash Flow pS5.90$
KEY FIGURES (LTM): Price info
Price/Book Ratio1.82
Price/Tangible Book Ratio0.00
Price/Cash Flow4.1
Price/Free Cash Flow4.7
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield6.4
Payout Ratio0.0
5-Y Average Payout Ratio30.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----0.1-313,379,77661,537,579
4 Weeks18.7114.8218.00-14.2-1916,250,368325,007,373
13 Weeks29.5713.7728.05-45.0-5117,643,3221,146,815,937
26 Weeks32.7513.7724.14-36.0-4422,245,2242,847,388,740
52 Weeks119.8713.7793.10-83.4-9622,728,8775,727,677,178
YTD105.9313.77--84.3-9723,523,9625,598,703,004
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
15.3915.8119.6023.5227.550.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.550.60.43
Income0.0
Dividend0.0
Capital Spending0.53NA0.50
R&D20.63NA26.42
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %24.824.844.0
Earnings %0.00.0-100.0
EPS %0.00.0-100.0
EPS $-0.05-0.05-0.87
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.40
Current Ratio1.0
Quick Ratio (Acid Test)0.6
Liquidity Ratio (Cash)0.22
Receivables Turnover4.4
Average Collection Period82
Working Capital/Equity3.3
Working Capital pS0.57
Cash-Flow pS6.42
Free Cash-Flow pS5.54
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.43
Financial Leverage Ratio (Assets/Equity)5.3
Debt Ratio63.5
Total Debt/Equity (Gearing Ratio)5.26
LT Debt/Equity5.12
LT Debt/Capital Invested102.0
LT Debt/Total Liabilities97.3
Interest Cover0.9
Interest/Capital Invested3.58
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.20
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA12.76
Enterprise Value (EV)/Free Cash Flow9.95
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM1.82
Price/Cash Flow Ratio4.1
Price/Free Cash Flow Ratio - LTM4.7
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM737.9
P/E Ratio (52 weeks ago) - LTM104.5
5-Y High P/E Ratio-89.7
5-Y Low P/E Ratio-6.3
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM93.3
PER SHARE FIGURES
LT Debt pS117.52
Current Liabilities pS20.63
Tangible Book Value pS - LTM-102.79
Book Value pS - LTM15.24
Capital Invested pS106.51
Cash pS - LTM0.00
Cash Flow pS - LTM6.68
Free Cash Flow pS - LTM5.90
Earnings pS (EPS)-0.85
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin18.16
Free Cash Flow Margin 5YEAR AVG-23.60
Net Profit Margin0.0
Net Profit Margin - 5YEAR AVRG.0.0
Equity Productivity1.77
Return on Equity (ROE)-0.1
Return on Equity (ROE) - 5YEAR AVRG.0.0
Capital Invested Productivity0.28
Return on Capital Invested (ROCI)0.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.0
Assets Productivity0.30
Return on Assets (ROA)0.0
Return on Assets (ROA) - 5YEAR AVRG.0.0
Gross Profit Margin75.3
Gross Profit Margin - 5YEAR AVRG.0.7
EBITDA Margin - LTM38.6
EBIT Margin - LTM13.5
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.0.0
Effective Tax Rate-142.5
Effective Tax Rate - 5YEAR AVRG.185.2
EFFICIENCY RATIOS
Cash Conversion Cycle32,292,838
Revenue per Employee474,841
Net Income per Employee
Average Collection Period32,292,838
Receivables Turnover4.4
Day's Inventory Turnover Ratio
Inventory Turnover2.3
Inventory/Sales12.0
Accounts Payble/Sales4.15
Assets/Revenue3.33
Net Working Capital Turnover53.68
Fixed Assets Turnover0.24
Total Assets Turnover0.3
Revenue per $ Cash17.49
Revenue per $ Plant7.25
Revenue per $ Common Equity1.77
Revenue per $ Capital Invested0.28
Selling, General & Adm/tive (SG&A) as % of Revenue25.8
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue3.2
R&D Expense as % of Revenue - 5YEAR AVRG.3.2

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.